Disease: Sezary syndrome
- [Translated article] Cost of Treating Cutaneous T-Cell Lymphoma in Spain: Analysis of MICADOS Study Data by Disease Stage
- "Next top" mouse models advancing CTCL research
- Abscopal Effect After Localized Radiotherapy in a Patient With Sezary Syndrome Under Treatment with Mogamulizumab
- Acute Exfoliative Dermatitis/Erythroderma Secondary to Gliclazide
- Advancements in the treatment of mycosis fungoides and Sézary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors
- Advances in Immunotherapy for the Treatment of Cutaneous T-Cell Lymphoma
- Advances in the treatment of mycoses fungoides and Sézary syndrome: a narrative update in skin-directed therapies and immune-based treatments
- Alemtuzumab as first- and second-line treatment in patients with Sézary Syndrome - the experience of a tertiary center
- Alemtuzumab as first- and second-line treatment in patients with Sézary syndrome-The experience of a tertiary centre
- Allogeneic stem cell transplant for treatment of mycosis fungoides and Sezary syndrome: a systematic review and meta-analysis
- Allogeneic transplantation and cellular therapies in cutaneous T-cell lymphoma
- Alopecia areata-like presentations with mogamulizumab therapy
- An occurrence of eosinophilic folliculitis and alopecia associated with a sustained complete response to mogamulizumab in Sezary syndrome: a case report
- An update on mechanisms of pruritus and their potential treatment in primary cutaneous T-cell lymphoma
- Association of Cardiovascular Disease in Patients with Mycosis Fungoides and Sezary Syndrome Compared to a Matched Control Cohort
- Bilateral peripheral ulcerative keratitis in a patient with known Sezary syndrome
- Bridging the specialty gap: Update on primary cutaneous lymphomas
- CD39 is expressed by a wide range of cutaneous T-cell lymphomas
- Changes to Registered and Pivotal Clinical Trials following the 2011 Tri-Societies Guidelines for Clinical Endpoints and Response Criteria in Mycosis Fungoides and Sézary Syndrome
- Characteristics of Primary Cutaneous Lymphoma in Italy: A Tertiary Care, Single-Center Study
- Characterizing Outcomes in Visceral Cutaneous T-Cell Lymphoma: A Single Center Retrospective Study
- Chemical exposures and demographic associations in cutaneous T-cell lymphoma: a large single institution physician validated cohort study
- Cinnamyl-Modified Polyglycidol/Poly(ε-Caprolactone) Block Copolymer Nanocarriers for Enhanced Encapsulation and Prolonged Release of Cannabidiol
- Clinical and Real-World Effectiveness of Mogamulizumab: A Narrative Review
- Clinical characteristics, initial treatment, and prognosis of mycosis fungoides and Sézary syndrome: A retrospective, single-center study at the Centre Hospitalier Universitaire of Quebec
- Clinical outcomes of COVID-19 in Mycosis Fungoides and Sezary Syndrome
- Clinicopathologic Features of Cutaneous T-Cell Lymphomas With Extracutaneous Metastasis: A Case Series
- Clinicopathological definition, management and prognostic value of mogamulizumab-associated rash and other cutaneous events: A systematic review
- Computational Flow Cytometry Accurately Identifies Sezary Cells Based on Simplified Aberrancy and Clonality Features
- Cost-utility analysis of mogamulizumab in advanced mycosis fungoides and Sézary syndrome cutaneous T-cell lymphoma
- Cutaneous Naganishia albida (Cryptococcus albidus) infection: a case report and literature review
- Cutaneous T-Cell Lymphoma and Microbiota: Etiopathogenesis and Potential New Therapeutic Targets
- Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature
- Cutaneous T-cell lymphoma-Focus on some problems, and some solutions
- Cutaneous T-cell Lymphomas: A Single-center Retrospective Analysis
- Deciphering Tumor Cell Evolution in Cutaneous T-Cell Lymphomas: Distinct Differentiation Trajectories in Mycosis Fungoides and Sézary Syndrome
- Die Wirkung von Mogamulizumab auf die aberrante T-Zell-Population im peripheren Blut - eine monozentrische retrospektive Analyse
- Dupilumab-associated mycosis fungoides: a cross-sectional study
- Dupilumab-Associated Sezary Syndrome
- Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study
- Early intervention of extracorporeal photopheresis for advancing/progressing cutaneous T-cell lymphoma
- EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome - Update 2023
- Epidemiologie reifzelliger T- und NK-Zell-Lymphome in Deutschland - Eine repräsentative Querschnittanalyse von GKV-Routinedaten: Epidemiology of mature T/NK-cell lymphomas in Germany - A representative cross-sectional study based on SHI claims data
- Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region
- Epidemiology of mature T/NK-cell lymphomas in Germany - A representative cross-sectional study based on SHI claims data
- Evaluation of Quality of Life and Treatment Satisfaction in Newly Diagnosed Cutaneous T-Cell Lymphoma Patients
- Evolution of patients with Sezary syndrome after mogamulizumab discontinuation for any cause except progression: a multicenter retrospective study (Moga-stop study)
- Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas
- Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas
- Extracorporeal Photopheresis in Dermatological Diseases
- Eyelid involvement of primary cutaneous lymphomas: A clinical perspective
- FISH Panel for Leukemic Cutaneous T-Cell Lymphoma: Extended Patient Cohort Correlation with Blood Involvement and Clinical Outcomes
- Gender disparities in health-related quality of life (HRQoL) in patients with cutaneous T-cell lymphoma
- Graft-versus-lymphoma effect in skin after allogeneic hematopoietic stem cell transplantation for Sézary syndrome
- Hair repigmentation in Sezary syndrome
- High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome
- Histopathological Markers for Target Therapies in Primary Cutaneous Lymphomas
- Immunobiology and treatment of cutaneous T-cell lymphoma
- Inflammatory arthritis complicating mogamulizumab treatment of Sézary syndrome
- International Study of SS Shows Superiority of Combination Therapy & Heterogeneity of Treatment Strategies
- Itchy Skin: A Challenging Differential Diagnosis Between Mycosis Fungoides and Sézary Syndrome
- JAAD Game Changers∗: Early clinical manifestations of Sézary syndrome: A multicenter retrospective cohort study
- Journal Club: Mycosis fungoides and Sezary syndrome: an update on a classic disease
- Long term outcomes of nonmyeloablative allogeneic stem cell transplantation with TSEB TLI and ATG for Mycosis Fungoides and Sezary Syndrome
- mAb14, a Monoclonal Antibody against Cell Surface PCNA: A Potential Tool for Sezary Syndrome Diagnosis and Targeted Immunotherapy
- Microenvironment-dependent growth of Sezary cells in humanized IL-15 mice
- Mogamulizumab Combined with Extracorporeal Photopheresis as a Novel Therapy in Erythrodermic Cutaneous T-cell Lymphoma
- Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sézary syndrome. Report of seven cases
- Mogamulizumab-Associated Myositis With and Without Myasthenia Gravis and/or Myocarditis in Patients With T-Cell Lymphoma
- Mycosis fungoides and Sézary syndrome following dupilumab treatment: experience of two Italian tertiary care centres
- New <em>JAK3-INSL3</em> Fusion Transcript-An Oncogenic Event in Cutaneous T-Cell Lymphoma
- Non-coding RNAs in the epigenetic landscape of cutaneous T-cell lymphoma
- Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care
- Paediatric cutaneous lymphomas including rare subtypes: A 40-year experience at a tertiary referral centre
- Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sezary Syndrome (BIO-MUSE): Protocol for a Translational Study
- Predictive and prognostic biomarkers in patients with Mycosis fungoides and Sezary syndrome (BIO-MUSE): Study protocol for a translational study
- Prevalence and implications of mogamulizumab-induced immune-related adverse events in mycosis fungoides/Sézary syndrome; a single-center experience
- Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates
- Primary cutaneous T-cell lymphoma: a review of the most common entities with focus on recent updates
- Racial Disparities in Mycosis Fungoides/Sezary Syndrome-A Single-Center Observational Study of 292 Patients
- Real-world study on the use of pegylated interferon alpha-2a for treatment of mycosis fungoides/Sezary syndrome using Time to Next Treatment as a measure of clinical benefit: An EORTC CLTG study
- Refractory mogamulizumab-associated rash responding to an oral Janus kinase inhibitor
- Role of IL-4 and IL-13 in Cutaneous T Cell Lymphoma
- Severe relapses of cutaneous T-cell lymphoma after treatment of chronic graft-versus-host disease with ruxolitinib
- Sezary syndrome initially presenting as pityriasis rubra pilaris: Clinicopathologic study of 3 cases
- Sézary syndrome originates from heavily mutated hematopoietic progenitors
- Staphylococcus aureus and Sezary syndrome
- Staphylococcus aureus induce drug resistance in cancer T cells in Sezary Syndrome
- Survival Analysis and Prognostic Factors in a Case Series of 148 Cutaneous T-Cell Lymphomas
- The effect of mogamulizumab on the aberrant T cell population in the peripheral blood - A monocentric retrospective analysis
- The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets
- Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open label phase 2 study
- Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study
- Trends in risk for therapy-related myelodysplastic syndrome/acute myeloid leukemia after initial chemo/immunotherapy for common and rare lymphoid neoplasms, 2000-2018
- Unleashed monocytic engagement in Sezary syndrome during the combination of anti-CCR4 antibody with type I interferon
- Unraveling the Mechanisms of PD-1 Regulation in Sézary Syndrome: Epigenetic Regulation as Potential Mechanism?
- Unveiling the hidden struggles: Exploring the profound impact of advanced stage cutaneous T-cell lymphoma on quality of life
- Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection
- Varied presentations of primary cutaneous lymphoma: A case series from a tertiary care center in South India
- What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?